Affirms FY25 operating margin view of 21% vs. 18.8% in FY24 and EBITDA margin view of about 30% vs. 27.4% in FY24. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on DXCM: DexCom affirms FY25 revenue view of $4.60B, consensus $4.61B DexCom reports Q4 EPS 45c, consensus 50c DexCom options imply 6.7% move in share price post-earnings Notable companies reporting after market close Is DXCM a Buy, Before Earnings? Disclaimer & DisclosureReport an Issue
